Article information
Full text is only aviable in PDF
Bibliografía
[1.]
P.J. Barnes.
Neuropeptides in the lung: localization, function and pathophysiologic implications.
J Allergy Clin Immunol, 79 (1987), pp. 285-295
[2.]
M. Jordana, J. Dolovich.
La nariz como espejo de los bronquios.
Arch Bronconeumol, 27 (1991), pp. 1-2
[3.]
L. Lundblad.
Neuropeptides and autonomic nervous control of the respiratory mucosa.
Rhinitis and asthma, pp. 65-75
[4.]
G.D. Raphael, H.M. Druce, J.N. Baraniuk, M.A. Kaliner.
Pathophysiology of rhinitis I Assessment of the sources of protein in methacholine-induced nasal secretions.
Am Rev Respir Dis, 138 (1988), pp. 413-420
[5.]
G.D. Raphael, M. Hauptschein-Raphael, M. Kaliner.
Gustatory rhinitis: a syndrome of food-induced rhinorrhea.
J Allergy Clin Immunol, 83 (1989), pp. 110-115
[6.]
G.D. Raphael, S.D. Meredith, J.N. Baraniuk, H.M. Druce, S.M. Banks, M.A. Kaliner.
The pathophysiology of rhinitis II Assessment of the sources of protein in histamine-induced nasal secretions.
Am Rev Respir Dis, 139 (1989), pp. 791-800
[7.]
P.J. Barnes.
Neural control of human airways in health and disease.
Am Rev Respir Dis, 134 (1986), pp. 1.289-1.314
[9.]
A.B.M. Klaassen, Y.J.B. Van Megen, W. Kuiphers, Van den Brock.
Autonomic innervation of the nasal mucosa.
ORL (Oto Rhino-Laryngol), 50 (1988), pp. 32-41
[10.]
G. Burnstock.
Autonomic neural control mechanisms With special reference to the airways.
Neural Control in Health and Diseases. Vol 33., pp. 1-22
[11.]
X.Y. Hua.
Tachykinins and calcitonin gene related peptide in relation lo peripheral functions at capsaicin-sensitive neurons.
Acta Physiol Scand, 127 (1986), pp. 1-45
[12.]
L. Lundblad.
Protective reflexes and vascular effects in the nasal mucosa elicited by activation of capsaicin-sensitive substance P-immunoreactive trigeminal neurons.
Acta Physiol Scand, 529 (1984), pp. l-l42
[13.]
P. Holtzer.
Local effector functions of capsaicin-sensitive sensorynerve endings: involvement of tachykinins, calcitonin-gene related peptide, and other neuropeptides.
Neuroscience, 24 (1988), pp. 739-768
[14.]
R. Uddman, F. Sundler.
Neuropeptides in the airways: a review.
Am Rev Respir Dis, 136 (1987), pp. S3-S8
[15.]
J.N. Baraniuk.
MA Kaliner. Neuropeptides and nasal secretion.
J Allergy Clin Immunol, 86 (1990), pp. 620-627
[16.]
P. Gepetti, C.A. Maggi, F. Perretti.
Simultaneous release by bradykinin of substance P and calcitonin gene related peptide immunoreactivities form capsaicin-sensitive guinea pig heart.
Br J Pharmacol, 94 (1988), pp. 288-296
[17.]
O. Iliopoulos, D. Proud, A.G. Togias, et al.
Immunopharmacology of nasal allergic reactions.
Am J Rhinol, 2 (1988), pp. 97-107
[18.]
J. Mullol, J.D. Lundgren, J.N. Baraniuk, C. Logun, J.H. Shelhamer, M.A. Kaliner.
The effect of neuropeptides upon glycoconjugate and lactoferrin reléase from human nasal mucosal explants.
Am Rev Respir Dis, 141 (1990), pp. A637
[19.]
A. Sana, C.R. Martiing, Z. Yan.
Reléase of múltiple tachykinins from capsaicin sensitive sensory nerves in the lung by bradykinin. histamine, dimethyl-piperazinium, and vagal nerve stimulation.
Am Rev Respir Dis, 137 (1988), pp. 1.330-1.336
[20.]
L.R. Steranka, D.C. Manning, C.J. DeHaas.
Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesia actions.
Proc Nati Acad Sci, 85 (1988), pp. 3.245-3.250
[21.]
T. Ishii.
The cholinergic innervation of the human nasal mucosa. A histochemical study.
Pract Oto-Rhino-Laryngol, 32 (1970), pp. 153-158
[22.]
A. Konno, K. Togawa.
Role of the vidian nerve in nasal allergy.
Ann Otol Rhinol Laryngol, 88 (1979), pp. 258-266
[23.]
J.M. Polak, S.R. Bloom.
Regulatory peptides of the gastrointestinal and respiratory tracts.
Arch Int Pharmacodyn Ther, 280 (1986), pp. 16
[24.]
G.D. Raphael, S.D. Meredith, J.N. Baraniuk, M.A. Kaliner.
Nasal reflexes.
Am J Rhinol, 2 (1988), pp. 8-12
[25.]
P.J. Barnes.
Neuropeptides in human airways: function and clinical implications.
Am Rev Respir Dis, 136 (1987), pp. S77-S83
[26.]
T.B. Cásale.
Airways neuropeptides.
Am J Rhinol, 2 (1988), pp. 121
[27.]
J.B. Palmer, F.M.C. Cuss, P.J. Barnes.
Sensory neuropeptides and human airway function.
Am Rev Respir Dis, 133 (1986), pp. A239
[28.]
P.J. Barnes.
Ashma and axon reflex.
Lancet, 1 (1986), pp. 242
[29.]
T. Hofkelt, B. Fuxe, Pernow.
Coexistence of neural messengers: a new principle in chemical transmission.
Prog Brain Res, 68 (1986), pp. 1-343
[30.]
A. Änggård, O. Densert.
Adrenergic innervation of the nasal mucosa in the cat.
Acta Otolaryngol (Stockh), 78 (1974), pp. 232-241
[31.]
A. Dahlstrom, K. Fuxe.
The adrenergic innervation of the nasal mucosa.
Acta Otolaryngol (Stockh), 59 (1965), pp. 65-70
[32.]
E.K. Potler.
Neuropeptide Y as an autonomic neurotransmittcr.
Pharmacol Ther, 37 (1988), pp. 201-209
[33.]
R. Uddman, F. Sundler.
Innervation of the upper airways.
Clin Chest Med, 7 (1986), pp. 201-209
[34.]
J.N. Baraniuk, M.A. Kaliner.
Neuropeptides in the upper and lower respiratory tracts.
Immunol Allergy Clin North, 10 (1990), pp. 383-407
[35.]
J.M. Lundberg, J. Fahrenkrug, O. Larson, A. Änggård.
Corelease of vasoactive intestinal peptide and peptide histidine isoleucine in relation to atropine-resistant vasodilation in cal submandibular salivary gland.
Neurosci Lett, 52 (1984), pp. 37-42
[36.]
J.M. Lundberg, A. Franco-Cereceda, X. Hua, T. Hokfeit, J.A. Fischer.
Coexistence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin.
Eur J Pharmacol, 108 (1985), pp. 315-319
[37.]
J.M. Lundberg, L. Lundbald, C.R. Martlin, A. Saria, P. Stijarne, A. Änggård.
Coexistence of multiple peptides and classical transmitlers in airways neurons: functional and pathophysiological aspects.
Am Rev Respir Dis, 136 (1987), pp. S16-S23
[38.]
P. Stjarne, L. Lundbald, J.M. Lundberg, A. Ängård.
Capsaicin and nicotine sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis.
Br J Pharmacol, 96 (1989), pp. 693-701
[39.]
S.D. Brain, T.J. Williams, P. Substance.
regulates the vasodilator activity of calcitonin gene related peptide.
Nature Lond, 335 (1988), pp. 73-75
[40.]
R. Gamse, A. Saria.
Potentiation of tachykinin induced plasma prolein extravasation by calcitonin gene related peptide.
Eur J Pharmacol, 114 (1985), pp. 61-66
[41.]
Z. Khalil, P.V. Andrews, R.D. Helme.
VIP modulates substance P-induccd plasma extravasation.
Eur J Pharmacol, 15 (1988), pp. 281-287
[42.]
J.N. Baraniuk, J.D. Lundgren, J. Goff, et al.
Gastrin-releasing peptide in human nasal mucosa.
J Clin Invest, 85 (1990), pp. 998-1.005
[43.]
J.N. Baraniuk, J.D. Lundgren, J. Goff, et al.
Calcitonin generelated peptide in human nasal mucosa.
Am J Physiol, 258 (1990), pp. L81-L88
[44.]
J.N. Baraniuk, S. Castellino, J.D. Lundgren, et al.
Neuropeptide Y (NPY) in human nasal mucosa.
Am J Respir Cell Mol Biol, 3 (1990), pp. 165-173
[45.]
J.N. Baraniuk, J.D. Lundgren, M. Okayama, et al.
Vasoactive intestinal peptide in human nasal mucosa.
J Clin Invest, 86 (1990), pp. 825-831
[46.]
J.N. Baraniuk, J.D. Lundgren, M. Okayama, et al.
Substance P and neurokinin a in human nasal mucosa.
Am J Respir Ccll Mol Biol, 4 (1991), pp. 228-236
[47.]
J. Widdicombe.
Nasal and pharyngeal reflexes: protective and respiratory functions.
pp. 233-258
[48.]
A. Togias, R.M. Naclerio, D. Proud, et al.
Studies on allergic and nonallergic nasal inflammation.
J Allergy Clin Immunol, 81 (1988), pp. 782-790
[49.]
R. Green, J. Fowler, D. McGlashan, D. Weinreich.
IgE challenged human lung mast cells excite vagal sensory neurons in vilro.
J Appl Physiol, 64 (1988), pp. 2.249-2.253
[50.]
D.B. Borson, J.A. Nadel.
Regulation of airways secretion: role of peptides and proteases.
Rhinitis and asthma., pp. 76-99
[51.]
K. Ohkubo, R.J. Hohman, H. Kaulbach, J.N. Hausfeid, M. Mérida, M.A. Kaliner.
Neutral endopcptidase (NEP) in human nasal mu cosa and nasal secretions.
J Allergy Clin Immunol, 87 (1991), pp. 145
[52.]
J.A. Nadel, D.B. Borson.
Modulation of neuropcptidc activity in the lungs by neutral endopeptidase Respiratory allergy.
BC Decker Inc, (1990), pp. 17-21
[53.]
J. Nadel.
Neuropeptide metabolism in airways by neutral endopeptidase.
Eur J Pharmacol, 183 (1990), pp. 93
[54.]
P. Panula.
Histochemistry and function of bombesin-like peptides. Med Biol (Helsinki), 64 (1986), pp. 177-192
[55.]
M.E. Sunday, L.M. Kaplan, E. Moloyama, W.W. Chin, E.R. Espindel.
Gastrin releasing peptide (mammalian bombesin) gene expression in health and disease.
Lab Invest, 59 (1988), pp. 5-24
[56.]
F. Cuittitta, J. Fedorko, J. Gu, A. Lebacq-Verheyden, R.I. Linnoila, J.F. Battey.
Gastrin releasing peptide associated peptides are expressed in normal human fetal lung and small cell lung cancer: a novel peptide family in man.
J Clin Endo Metab, 67 (1988), pp. 576-583
[57.]
E. Bork, M. Hansen, P. Urdal, et al.
Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatine kinase, neuron specific enolase. calcilonin, ACTH. serotonin. and gastrin releasing peplide.
Eur J Cancer & Clin Oncol, 24 (1988), pp. 1.033-1.038
[58.]
Y. Haragushi, A. Sakamolo, T. Yoshida, K. Tanaka.
Plasma GRP-like immuno-reactivity in healthy and diseased subjects.
Gastrocnterol Jpn, 23 (1988), pp. 247-250
[59.]
R. Uddman, E. Moghimzadeh, F. Sundler.
Occurcnce and distribution of GRP-immunoreactive nerve fibres in the respiratory tract.
Arch Otolaryngol, 239 (1984), pp. 145-151
[60.]
P. Helen, P. Panula, H.Y.T. Yang, A. Hervonen.
Rapaport SI. Location of substance P–, bombesin-gastrin-releasing peptide. met–5]enkephalin–, and met[5].enkephalin-arg6-phe7-like immunoreactivities in adult human sympathetic ganglia.
Neuroscience, 12 (1984), pp. 907-916
[61.]
S. Kentrote, W.L. Dees, S.M. McCann.
Evidencc for a physiological role of hypothalamic gastrin-releasing peptide to suppress growth hormone and prolactin release in the rat.
Proc Natl Acad Sci USA, 85 (1988), pp. 953-957
[62.]
E.R. Spindel, M.E. Sunday, H. Hofler, H.J. Wolfe, J.F. Habener, W.W. Chin.
Transient elevation of mRNAs encoding gastrin releasing peptide (GRP). a putativo pulmonary growth factor, in human fetal lung.
J Clin Invest, 80 (1987), pp. 1.172-1.179
[63.]
J.C. Willey, J.F. Lechncr, C.C. Harris.
Bombesin and the C-terminal tetradecapeptide of gastrin releasing peptide are growh factors for normal human bronchial epithclial cells.
Exp Cell Res, 153 (1984), pp. 245-248
[64.]
R.W. Alexander, J.R. Upp Jr., G.J. Poston, V. Gupta, C.M. Townsend Jr., J.C. Thompson.
Effects of bombesin on growth of human small cell lung carcinoma in vivo.
Cancer Res, 48 (1988), pp. 1.439-1.441
[65.]
F. Cuittitta, D.N. Carney, J. Mulshine, et al.
Bombesin-like peptides can function as autocrine growth faclors in human small cell lung cancer.
Nature Lond, 316 (1985), pp. 823-826
[66.]
J.D. Lundgren, N.L. Ostrowski, J.N. Baraniuk, M.A. Kaliner, J.H. Shelhamer.
Gastrin releasing peptide causes glycoconjugate re léase from feline airway organ cultures.
Clin Res, 36 (1988), pp. 803A
[67.]
C. Damg’e, A. Hajri, E. Lhoste, M. Aprahamian.
Comparativo effect of chronic bombesin, gastrin releasing peptide and cacrulein on the ral páncreas.
Regul Pepl, 20 (1988), pp. 141-150
[68.]
H. Shinozaki, A. Funokoshi.
Evidcnce for the direct action of gastrin releasing peptide (GRP) on amylase secretion from rat pancrcatic acini: an assessment using a perfusion system.
Jpn J Physiol, 38 (1988), pp. 299-307
[69.]
J.J. Holst, S. Knuhtscn, C. Orskov, et al.
GRP nerves in pig antrum: role of GRP in vagal control of gastrin secretion.
Am J Physiol, 253 (1987), pp. G643-G649
[70.]
H.J. Lenz.
CNS regulation of gastric and autonomic functions in dogs by gastrin releasing peptide.
Am J Phsysiol, 255 (1988), pp. G298-G303
[71.]
H.R. Morris, M. Panico, T. Etienne, J. Tippins, S.I. Girgis, I. Madntyre.
Isolation and characterization of human calcitonin gene-related peptide.
Nature, 308 (1984), pp. 726-748
[72.]
M.G. Rosenfeld, J.J. Mermod, S.G. Amara, et al.
Production of a novel neuropeptide encoded by the calcitonin gene via tissue specific RNA-processmg.
Nature, 304 (1983), pp. 129-135
[73.]
I.L. Gibbins, D. Wallchow, B. Coventry.
Two immunohisto chemically identified populations of calcitonin gene related peptide (CGRP) immunoreactive axons in human skin.
Brain Res, 414 (1987), pp. 143-148
[75.]
R.A. Cridland, J.L. Henry.
Effecis of intrathecal administration of neuropeptides on a spinal nociceptive reflex in the rat: VIP, galanin CGRP, TRH, somatostatin, and angiotensin II.
Neuropetides, 11 (1988), pp. 23-32
[76.]
P.A. Harmann, K. Chung, R.P. Briner, K.N. Westlund, S.M. Carlton.
Calcitonin gene related peptide (CGRP) in the human spinal cord: a light and electron microscopio analysis.
J Comp Neurol, 269 (1988), pp. 371-380
[77.]
J.M. Lundberg, A. Saria, L. Lundiab, et al.
Bioactive peptides in capsaicinsensitive C-fiber afferents of the airways: Functional and pathophysiological implications.
The airways, neural control in health and disease. VoL 33., pp. 417-445
[78.]
J.C.M. Mak, P.J. Barnes.
Autoradiographic localization of calci tonin gene related peptide binding sites in human and guinea pig lung.
Peptides, 9 (1988), pp. 957-964
[79.]
I. Jansen, M. Ruddman, E.T. Hocherman, et al.
Localization and efects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene related peptide in human temporal arteries.
Ann Neurol, 20 (1986), pp. 496-501
[80.]
A.D. Struthers, M.J. Brown, D.W. McDonaId, et al.
Human calcitonin gene related peptide: a potent endogenous vasodilator in man.
Clin Sci Lond, 70 (1986), pp. 389-393
[81.]
B. Aursudkij, P.J. Barnes, M.G. Belvisi, S. Dijk, D.F. Rogers.
Effects of substance P, neurokinins and calcitonin gene related pepti de in microvascular permeability in guinea pig airways.
J Physiol, 398 (1988), pp. 51P
[82.]
S.J. Coles, K.R. Bhaskar, D.D. O'Sullivan, K.H. Neill, L.M. Reid.
Airway mucus: composition and regulation of its secretion by neuro peptides in vitro.
C’iba Found Symp, 109 (1984), pp. 40-60
[83.]
M.L. Kowaiski, M.A. Kaliner.
Neurogenic inflammation, vas cular permeability, and mast cells.
J Immunol, 140 (1988), pp. 3.905-3.911
[84.]
J.B.D. Palmer, F.M.C. Cuss, J.B. Warren, et al.
Calcitonin generelated peptide is localizcd to human airway nerves and potently constricts human airway smooth muscle.
Br J Pharmacol, 91 (1987), pp. 95
[85.]
J. Mullol, R.D. Rieves, J.N. Baraniuk, et al.
Neuropeptide ef fects of humán nasal glandular secretion in vitro.
Eur Respir J, 4 (1991), pp. 312a
[86.]
Y. Masu, K. Nakayama, H. Tamaki, Y. Haada, M. Kuno, S. Nakanishi.
cDNA cloning of bovine substance K receptor through picyte expression system.
Nature, 329 (1987), pp. 836-838
[87.]
Y. Yokota, Y. Sasai, K. Tanaka, et al.
Molecular characteriza tion of a functional cDNA for ral substance P receptor.
J Biol Chem, 264 (1989), pp. 17.649-17.652
[88.]
J.M. Lundberg, T. Hokfell, C.R. Martiing, A. Saria, C. Cuello.
Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man.
Cell Tissue Res, 235 (1984), pp. 251-261
[89.]
J.R. Carstairs, P.J. Barnes.
Autoradiographic mapping of subs tance P receptors in lung.
Eur J Pharmacol, 127 (1988), pp. 295-296
[90.]
Y. Masu, H. Tamaki, Y. Yokota, S. Nakanishi.
Tachykinin precursors and receptors, molecular genetic studies.
Regul Pepl, 22 (1988), pp. 9-12
[91.]
R. Quiron, T.V. Dam.
Multiple neurokinin receptors: recent developments.
Regul Pept, 22 (1988), pp. 18-25
[92.]
D. Regoli.
Peptide receptors in the airwavs.
Am Rev Respir Dis, 136 (1987), pp. S35-S39
[93.]
M. Lotz, J.H. Vaughan, D.A. Carson.
Effect of neuropeptides on production of inflammatory cytokines by human monocytes.
Science, 241 (1988), pp. 1.218-1.221
[94.]
T.W. Evans, C.M. Dixon, B. Clarke, T.B. Conradson, P.J. Barnes.
Companson of neurokinin A and substance P on cardiovascular and airway function in man.
Br J Clin Pharmacol, 25 (1988), pp. 273-275
[95.]
X.Y. Hua, J.M. Lundberg, E. Thodorsson-Norheim, E. Brodin.
Comparison of cardiovascular and bronchoconstrictor effects of substance K., and other tachykinins.
Naunyn Schiedebergs Aren Pharmacol, 328 (1984), pp. 196-201
[96.]
G. Jóos, R. Pauwels, M. Van der Straeten.
Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects.
Thorax, 42 (1987), pp. 779-783
[97.]
T. Lee, Y. Kawai, S. Shiosaka.
Coexistence of calcitonin generelated peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis.
Brain Res, 330 (1985), pp. 194-196
[98.]
J.D. Lundgren, C.J. Wiedermann, C. Logun, J. Plutchok, M. Kali ner, J.H. Shelhamer.
Substance P receptor mediated secretion of respiratory glycoconjugate from feline airways in vitro.
Exp Lung Res, 15 (1989), pp. 17-29
[99.]
K. Tatemoko.
Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion.
Proc Natl Acad Sci USA, 79 (1982), pp. 2.514-2.518
[100.]
K. Tatemoto, M. Carlquist, V. Mutt, Y. Neuropeptide.
A novel brain peptide with structural similarities to peptide YY and pancrea tic peptide.
Nature (London), 296 (1982), pp. 659-660
[101.]
J.M. Lundberg, L. Terenius, T. Hokfelt, et al.
Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function.
Acta Physiol Scand, 116 (1982), pp. 477-480
[102.]
J.M. Lundberg, L. Terenius, T. Hokfelt, M. Goldstein.
High levels of neuropeptide Y (NPY) in peripheral noradrenergic neurons in various mammals including man.
Neurosci Lett, 42 (1983), pp. 167-172
[103.]
G. Fried, J.M. Lundberg, E. Theodorsson-Norheim.
Subcellular storage and axonal transpon of neuropeptide Y (NPY) in relation to catecholamines in the cat.
Acta Physiol Scand, 125 (1985), pp. 145-154
[104.]
G. Fried, L. Terenius, T. Hokfelt, M. Goldstein.
Evidence for differential localization of noradrenaline and neuropeptide Y (NPY) in neuronal storage vesicles isolated from vas deferens.
J Neurosci, 5 (1985), pp. 450-458
[105.]
B. Weaber, Y Neuropéptido.
¿Un eslabón perdido?.
Hospital Practice (ed esp), 6 (1991), pp. 58-66
[106.]
M.N. Sheppard, J.M. Polak, J.M. Allen, S.R. Bloom.
Neuropepti de tyrosine (PPY): a newly discovered peptide is present in the mammalian respiratory tract.
Thorax, 39 (1984), pp. 326-330
[107.]
L. Lundblad, A. Änggård, A. Saria, J.M. Lundberg.
Neuropepti de Y and non-adrenergic sympathelic vascular control of the cat nasal mucosa.
J Aulon Nerv Syst, 20 (1987), pp. 189-197
[108.]
A. Codieux, M.T. Benchektoun, S. St-Pierre, A. Fourier.
Bron choconstrictor action of neuropeptide Y (NPY) in isolaled guineapig airways.
Neuropeptides, 13 (1989), pp. 215
[109.]
R. Eccies.
Neurological and pharmacological considerations.
The nose: upper airway physiology and the atmospheric environment, pp. 191-214
[110.]
J.N. Baraniuk.
Neural control of human nasal secretion.
Pulm Pharmacol, 4 (1991), pp. 20-31
[111.]
S.I. Said, V. Mutt.
Long acting vasodilator peptide from lung tissue.
Nature, 224 (1969), pp. 699-700
[112.]
S.I. Said, V. Mutt.
Vasoactive intestinal peptide and related peptides.
Ann NY Acad Sci, 527 (1988), pp. 1-689
[113.]
M. Costa, J.B. Furness, I.L. Gibbons, et al.
Colocalization of VIP wilh olher neuropeptides and neurotransmitters in the autono mic nervous system.
Ann NY Acad Sci, 527 (1988), pp. 103-109
[114.]
F. Sunler, E. Ekblad, T. Grunditz, R. Hakanson, R. Uddman.
VIP in the peripheral nervous system.
Ann NY Acad Sci, 527 (1988), pp. 143-147
[115.]
O. Larsson, M. Duner-Engstrom, J.M. Lundberg, B.B. Freholm.
Änggård. Effects of VIP, PHM and substance P on blood vessels and secretory elements of the human submandibular gland. Regul Pepl, 13 (1986), pp. 319-326
[116.]
L. Malm, F. Sundler, R. Uddman.
Effects of vasoactive intesti nal peptide (VIP) on resistance and capacitance vessels in nasal mucosa.
Acta Otolaryngol (Stockh), 90 (1980), pp. 304-308
[117.]
J. Mullol, G.D. Raphael, J.D. Lundgren, et al.
Comparison of human nasal secretion in vivo and in vitro.
J Allergy Clin Immunol, 89 (1992), pp. 584-592
[118.]
J.M. Lundberg, A. Änggård, J. Fahrenburg, O. Johansson, T. Hokfelt.
Vasoactive intestinal peptide in cholinergic neurons of exocrine glands.
Vasoactive intestinal peptide., Raven Press SI.Said, (1982), pp. 373-379
[119.]
A. Laitinen, M. Partanen, A. Heruonen, M. Peto-Huikko, L.A. Laitinen.
VIP-like immunoreactive nerves in human respiratory tract: light and electron microscopic study.
Histochemistry, 82 (1985), pp. 313-319
[120.]
J.R. Carstairs, P.J. Barnes.
Visualization of vasoactive intesti nal peptide receptors in human and guinea pig lung.
J Pharmacol ExpTher, 239 (1986), pp. 249-255
[121.]
S.C. Lazarus, C.B. Basbaum, P.J. Barnes, W.M. Gold.
cAMP immunocytochemistry provides evidence for functional VIP recep tors in trachea.
Am J Physiol, 251 (1986), pp. C115-C119
[122.]
S.I. Said.
Vasoactive peptides in the lung, with special reference to vasoactive intestinal peptide.
Exp Lung Res, 3 (1982), pp. 343-348
[123.]
A.A. Gashi, D.B. Borson, W.E. Finkbeiner, J.A. Nadel, C.B. Basbaum.
Neuropeptides degranulate serous cells of ferret tracheal glands.
Am J Physiol, 251 (1986), pp. C223-C229
[124.]
A.C. Peatfield, P.J. Barnes.
Bratcher. Vasoactive intestinal pep tide stimulated tracheal submucosal gland secretion in ferret.
Am Rev Respir Dis, 128 (1983), pp. 89-93
[125.]
S. Shimura, S. Sasaki, H. Sasaki, T. Takishima.
VIP augments cholinergic-induced glycoconjugate secretion in tracheal submucosal glands.
J Appl Physiol, 65 (1988), pp. 2.537-2.544
[126.]
P.S. Richardson, S.E. Webber.
The control of mucous secretion in the airways by peptidergic mechanisms.
Am Rev Respir Dis, 136 (1987), pp. S72-S76
[127.]
S.J. Coles, S.I. Said, L.M. Reid.
Inhibition by vasoactive intesti nal peptide of glycoconjugate and lysozyme secretion by human airways in vitro.
Am Rev Respir Dis, 124 (1981), pp. 531-536
[128.]
A. Cheung, J.M. Polak, F.E. Bauer, et al.
The distribution of galanin immunoreactivity in the respiratory tract of pig, guinea pig, ral and dog.
Thorax, 40 (1985), pp. 889-896
[129.]
M.A. Gathei, M. Sheppard, D.J. O'Shaunessy, et al.
Regulatory peptides in the mammalian respiratory tract.
Endocrinology, 111 (1982), pp. 1.248-1.254
[130.]
M. Yanagisawa, H. Kurihara, S. Kimura, et al.
A novel potent vasoconstrictor peptide produced by vascular endothelial cells.
Nature, 332 (1988), pp. 411-415
[131.]
G. De Nucci, R. Thomas, P. D’Orleans-Juste, et al.
Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endo-thelin-derived relaxing factor.
Proc Natl Acad Sci USA, 85 (1988), pp. 9.797-9.800
[132.]
A. Nomura, Y. Uchida, M. Ohtsuka.
Endothelium-derived polypeptide potently constricts human bronchi.
Am Rev Respir Dis, 139 (1989), pp. A468
[133.]
Y. Uchida, H. Ninomiya, M. Saotome, et al.
Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor.
Eur J Pharmacol, 154 (1988), pp. 227-228
[134.]
S. Mattoli, M. Mezzetti, G. Riva, L. Allegra, A. Fasoli.
Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin-like material from bronchial epithelial cells.
Am J Respir Cell Mol Biol, 3 (1990), pp. 145-151
[135.]
Mullol J, Ohkubo K, Rieves RD, Hausfeid JH, Shelhamer JH. Kaliner MA. Endothelin in human nasal mucosa. J Allergy Clin Immunol (En revisión).
[136.]
S.S. Kurian, M.A. Blank, M.N. Sheppard, et al.
Vasoactive intes tinal polypeptide (VIP) in vasomotor rhinitis.
Clin Biochem, 11 (1983), pp. 425
[137.]
P. Heinz-Erian, R.D. Dey, M. Flux, S.I. Said.
Deffícient vasoac tive intestinal peptide innervation in sweat glands of cystic fibrosis patients.
Science, 229 (1985), pp. 1.407-1.408
[138.]
S.L. Ollerenshaw, D.L. Jarvis, A.J. Woolcok, T. Scheibner, C.E. Sullivan.
Substance P immunoreactive nerve fibres in airways from patients with and without asthma.
Am Rev Respir Dis, 139 (1989), pp. A237
[139.]
S.L. Ollerenshaw, D.L. Jarvis, A.J. Woolcock, C.E. Sullivan, T. Scheibner.
Absence of immunoreactive vasoactive intestinal poly peptide from the lungs of patients with asthma.
N Engl J Med, 320 (1989), pp. 1.244-1.248
[140.]
P.J. Barnes, J.M. Lundberg.
Airway neuropeptides and asthma.
pp. 385-407
[141.]
P.J. Barnes.
CMS Dixon. The effect of inhaled vasoactive intestinal peptide on bronchial hyperreactivity in man.
Am Rev Respir Dis, 130 (1984), pp. 162
[142.]
A. Nomura, Y. Uchida, M. Kameyama, M. Saotome, K. Oki, S. Hasegawa.
Endothelin and bronchial asthma.
Lancet, 2 (1989), pp. 747-748
[143.]
J.C. Foreman.
Neuropeptides and the pathogenesis of allergy.
Allergy, 42 (1987), pp. 1-11
[144.]
E.J. Goetzl, P.P.J. Cheng, A. Hassner, D.C. Adelman, O.L. Frick, S.P. Sredharan.
Neuropeptides, mast cells and allergy: novel mecha nisms and therapeutic possibilities.
Clin Exp Allery, 20 (1990), pp. 3-7
Copyright © 1993. Sociedad Española de Neumología y Cirugía Torácica
